Literature DB >> 2647024

The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss.

M C Foster1, P W Wenham, P A Rowe, R P Burden, A G Morgan, R E Cotton, R W Blamey.   

Abstract

The results of 279 renal transplants performed in a single centre between 1974 and 1986 are reviewed. Improvements in the management of acute rejection and a reduction in mortality have resulted in an improvement in 1-year actuarial graft survival rates from 44% for transplants performed before 1980 to 68% for those performed after 1983. After the second year post-transplant there has been a steady rate of graft failure (6% per annum), mainly due to chronic rejection. In total 52 grafts have developed chronic rejection (19% of the total and 30% of those at risk at 6 months). Chronic rejection is assuming greater relative importance as a cause of graft loss as early results improve.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647024      PMCID: PMC2498874     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  13 in total

1.  Kidney transplants in the United Kingdom.

Authors:  B A Bradley; N H Selwood; P T Klouda; W R Gilks; S M Gore; T R Ray; D Moras; M Riggulsford
Journal:  Clin Transpl       Date:  1986

2.  Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants.

Authors:  P Kincaid-Smith
Journal:  Lancet       Date:  1969-11-01       Impact factor: 79.321

3.  Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.

Authors:  D M Canafax; R L Simmons; D E Sutherland; D S Fryd; M H Strand; N L Ascher; W D Payne; J S Najarian
Journal:  Transplant Proc       Date:  1986-04       Impact factor: 1.066

4.  Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European multicentre trial.

Authors:  R Y Calne; A J Wood
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

5.  Plasma exchange in chronic renal allograft rejection.

Authors:  A Hendrick; J D Wallin; W M O'Neill
Journal:  Transplantation       Date:  1984-03       Impact factor: 4.939

6.  Long-term results of renal transplantation in recipients with a functioning graft for 2 years.

Authors:  R Abele; A C Novick; W E Braun; D Steinmuller; C Buszta; R Greenstreet; J Hinton
Journal:  Transplantation       Date:  1982-11       Impact factor: 4.939

7.  Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function.

Authors:  C Leithner; H Sinzinger; M Schwarz
Journal:  Prostaglandins       Date:  1981-11

8.  Calculations on long-term graft and patient survival in human kidney transplantation.

Authors:  G Opelz; M R Mickey; P I Terasaki
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

9.  Advantages of low dose steroid from the day after renal transplantation.

Authors:  M G McGeown; J F Douglas; W A Brown; R A Donaldson; J A Kennedy; W G Loughridge; S Mehta; S D Nelson; C C Doherty; R Johnstone; G Todd; C M Hill
Journal:  Transplantation       Date:  1980-04       Impact factor: 4.939

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  6 in total

Review 1.  Current status of renal transplantation.

Authors:  M G Suranyi; B M Hall
Journal:  West J Med       Date:  1990-06

Review 2.  The design and development of an immunosuppressive drug, mycophenolate mofetil.

Authors:  A C Allison; E M Eugui
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection.

Authors:  S G Tullius; U Heemann; W W Hancock; H Azuma; N L Tilney
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

4.  Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.

Authors:  M Tanabe; S Todo; N Murase; W Irish; H Miyazawa; S Fujisaki; T E Starzl
Journal:  Transplantation       Date:  1994-07-15       Impact factor: 4.939

5.  Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s.

Authors:  E J Schweitzer; A J Matas; K J Gillingham; W D Payne; P F Gores; D L Dunn; D E Sutherland; J S Najarian
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

6.  Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients.

Authors:  E Reed; E Ho; D J Cohen; W Ramey; C Marboe; V D'Agati; E A Rose; M Hardy; N Suciu-Foca
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.